AWM Investment Company, Inc. filed Amendment No. 2 to a Schedule 13G with the SEC on November 13, 2026, disclosing beneficial ownership of 427,765 shares of SANUWAVE Health, Inc. common stock as of September 30, 2026.
Key Highlights
- Total beneficial ownership: AWM Investment Company, Inc. reported aggregate beneficial ownership of 427,765 shares of SANUWAVE Health, Inc. common stock, representing 4.9% of the class.
- Sole voting and dispositive power: AWM holds sole voting power and sole dispositive power over all 427,765 shares, with no shared voting or dispositive power reported.
- Fund-level breakdown: The shares are held across four funds: 70,270 shares by Special Situations Cayman Fund, L.P.; 246,961 shares by Special Situations Fund III QP, L.P.; 54,162 shares by Special Situations Private Equity Fund, L.P.; and 56,372 shares by Special Situations Life Sciences Fund, L.P.
- Triggering event date: The date of the event requiring this filing was September 30, 2026, according to the document.
- Controlling principals: David M. Greenhouse and Adam C. Stettner are identified as controlling principals of AWM and members of the general partner entities of each fund.
- Ownership threshold: The filing was made under Item 5, "Ownership of 5 Percent or Less of a Class."
AWM Investment Company Discloses Sub-5% Position in SANUWAVE Health Across Four Funds
AWM Investment Company, Inc., a Delaware corporation registered as an investment adviser, filed Amendment No. 2 to Schedule 13G disclosing its beneficial ownership position in SANUWAVE Health, Inc. (NASDAQ:SNWV), whose common stock carries a par value of $0.001 per share and CUSIP number 80303D305. According to the filing, the event triggering the amendment occurred on September 30, 2026, with the statement signed by Adam Stettner, Executive Vice President, on November 13, 2026.
As described in the filing, AWM serves as investment adviser to four funds: Special Situations Cayman Fund, L.P. (CAYMAN), Special Situations Fund III QP, L.P. (SSFQP), Special Situations Private Equity Fund, L.P. (SSPE), and Special Situations Life Sciences Fund, L.P. (SSLS). In that capacity, AWM holds sole voting and investment power over 70,270 shares held by CAYMAN, 246,961 shares held by SSFQP, 54,162 shares held by SSPE, and 56,372 shares held by SSLS, for an aggregate of 427,765 shares. Shared voting and shared dispositive power are each reported as zero.
The filing further identifies David M. Greenhouse and Adam C. Stettner as members of the general partner entities for each of the four funds and as controlling principals of AWM. The aggregate position of 427,765 shares represents 4.9% of the class, placing the ownership below the 5% threshold, as confirmed under Item 5 of the filing. The certifying statement included in the filing states that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."
What Was Disclosed
AWM Investment Company, Inc. filed Amendment No. 2 to Schedule 13G reporting beneficial ownership of 427,765 shares, or 4.9%, of SANUWAVE Health, Inc. common stock as of September 30, 2026, held across four affiliated investment funds with sole voting and dispositive power retained by AWM.



Please wait processing your request...